Research - Cancer Drug Programmes
The human body is usually an extremely well regulated organism continually fighting attack from injury and disease to maintain good health. So the emergence of cancer is due to many facets of the body's regulatory system being overcome in order for the disease to prevail. For this reason providing treatment that attacks a cancer in more than one way provide a greater chance of therapeutic success.
Sareum's strategy for generating new treatments for cancer is two-pronged. Firstly we are working on drugs which target single enzyme pathways within cancer cells, which will then be used in combination with existing drugs to greatly improve the effect of these drugs (programmes 1 & 2). Secondly we are working on drugs which by themselves simultaneously target several different biochemical pathways (programme 3) known to be used by invading cancer cells, which will then be used as single agents in cancer patients refractory to current therapies.
Current Drug Discovery Pipeline
Requires RSS news reader
Requires MS Word
Requires Adobe Acrobat Reader